[Effect of fominoben on the arterial blood gases in obstructive diseases of the respiratory tract].
D000402:Airway Obstruction / Q000188:drug therapy*; D000577:Amides / Q000494:pharmacology / Q000627:therapeutic use; D000605:Amino Alcohols / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology / Q000627:therapeutic use; D000813:Anilides / Q000494:pharmacology / Q000627:therapeutic use; D000996:Antitussive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001784:Blood Gas Analysis; D001996:Bronchopneumonia / Q000188:drug therapy; D002245:Carbon Dioxide / Q000097:blood*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006801:Humans; D008744:Methylamines / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009025:Morpholines / Q000494:pharmacology* / Q000627:therapeutic use; D010100:Oxygen / Q000097:blood*; D010313:Partial Pressure; D012125:Respiratory Center / Q000187:drug effects
D000577:Amides; D000605:Amino Alcohols; D000613:Aminobutyrates; D000813:Anilides; D000996:Antitussive Agents; D004338:Drug Combinations; D008744:Methylamines; D009025:Morpholines; D002245:Carbon Dioxide; D010100:Oxygen
Einfluss von Fominoben auf die arteriellen Blutgase bei obstruktiven Atemwegserkrankungen.